Trial intelligence / Profile preview

Unecritinib adjuvant therapy in early resected NSCLC

CTR20223411Phase 3Terminated

Sponsor

Chia Tai-Tianqing Pharmaceutical Group

Start

Jan 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1